Exact Mass: 419.28

Exact Mass Matches: 419.28

Found 204 metabolites which its exact mass value is equals to given mass value 419.28, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

Ethamoxytriphetol

4-Methoxy-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol

C27H33NO3 (419.246)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists

   

Dehydroxypaxilline

(1S,2S,5S,7R,14S)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.02,11.05,10.016,24.017,22]tetracosa-9,16(24),17,19,21-pentaen-8-one

C27H33NO3 (419.246)


Dehydroxypaxilline is a metabolite of Emericella striata. Metabolite of Emericella striata

   

N-Palmitoyl tyrosine

(2S)-2-[(1-hydroxyhexadecylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

C25H41NO4 (419.3035)


N-palmitoyl tyrosine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Tyrosine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl tyrosine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl tyrosine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Hericerin

6-[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-2,3-dihydro-1H-isoindol-1-one

C27H33NO3 (419.246)


Hericerin is found in mushrooms. Hericerin is isolated from the edible lions mane mushroom (Hericium erinaceum). Isolated from the edible lions mane mushroom (Hericium erinaceum). Hericerin is found in mushrooms. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

   

Stearidonyl carnitine

3-[(4Z,8Z,12Z,15Z)-octadeca-4,8,12,15-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate

C25H41NO4 (419.3035)


Stearidonyl carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.) [HMDB] Stearidonyl carnitine is an acylcarnitine. Numerous disorders have been described that lead to disturbances in energy production and in intermediary metabolism in the organism which are characterized by the production and excretion of unusual acylcarnitines. A mutation in the gene coding for carnitine-acylcarnitine translocase or the OCTN2 transporter aetiologically causes a carnitine deficiency that results in poor intestinal absorption of dietary L-carnitine, its impaired reabsorption by the kidney and, consequently, in increased urinary loss of L-carnitine. Determination of the qualitative pattern of acylcarnitines can be of diagnostic and therapeutic importance. The betaine structure of carnitine requires special analytical procedures for recording. The ionic nature of L-carnitine causes a high water solubility which decreases with increasing chain length of the ester group in the acylcarnitines. Therefore, the distribution of L-carnitine and acylcarnitines in various organs is defined by their function and their physico-chemical properties as well. High performance liquid chromatography (HPLC) permits screening for free and total carnitine, as well as complete quantitative acylcarnitine determination, including the long-chain acylcarnitine profile. (PMID: 17508264, Monatshefte fuer Chemie (2005), 136(8), 1279-1291., Int J Mass Spectrom. 1999;188:39-52.).

   

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoylcarnitine

3-(octadeca-6,9,12,15-tetraenoyloxy)-4-(trimethylazaniumyl)butanoate

C25H41NO4 (419.3035)


(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoylcarnitine is an acylcarnitine. More specifically, it is an (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-Oleoyl Histidine

2-[(1-Hydroxyoctadec-9-en-1-ylidene)amino]-3-(1H-imidazol-5-yl)propanoate

C24H41N3O3 (419.3148)


N-oleoyl histidine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Oleic acid amide of Histidine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Oleoyl Histidine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Oleoyl Histidine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

N-Arachidonoyl Aspartic acid

2-[(1-Hydroxyicosa-5,8,11,14-tetraen-1-ylidene)amino]butanedioate

C24H37NO5 (419.2672)


N-arachidonoyl aspartic acid, also known as N-arachidonoyl aspartate belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Aspartic acid. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Aspartic acid is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Aspartic acid is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

11-Deoxycortisol-3-carboxymethyloxime

2-({[14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-ylidene]amino}oxy)acetic acid

C23H33NO6 (419.2308)


   

N-Formyl-Nle-Leu-Phe

2-[[2-(2-Formamidohexanoylamino)-4-methylpentanoyl]amino]-3-phenylpropanoic acid

C22H33N3O5 (419.242)


   

N-(2-Carboxyphenyl)retinamide

2-[3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamido]benzoic acid

C27H33NO3 (419.246)


   
   

8-Ethoxysachaconitine

8-Ethoxysachaconitine

C25H41NO4 (419.3035)


   
   
   

Dehydroxypaxilline

7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0^{2,11}.0^{5,10}.0^{16,24}.0^{17,22}]tetracosa-9,16(24),17,19,21-pentaen-8-one

C27H33NO3 (419.246)


   

11,12,13-trihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-1H,2H,3H,4H,6aH,9H,10H,11H,12H,13H,14H,15H,15bH-cycloundeca[e]isoindole-1,15-dione

11,12,13-trihydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-1H,2H,3H,4H,6aH,9H,10H,11H,12H,13H,14H,15H,15bH-cycloundeca[e]isoindole-1,15-dione

C24H37NO5 (419.2672)


   
   

11-hydroxydaphnigracine|methyl (4SR,6RS,6RS,8aRS,9RS,10aRS,11SR)-2,3,4,5,5,6,6,7,8,8a,9,10-dodecahydro-6,6-dihydroxy-2-methyl-6-(1-methylethyl)-1H,4H-spiro{4,10a-methanopentaleno[1,6-cd]azonine-11,3-pyran}-9-carboxylate

11-hydroxydaphnigracine|methyl (4SR,6RS,6RS,8aRS,9RS,10aRS,11SR)-2,3,4,5,5,6,6,7,8,8a,9,10-dodecahydro-6,6-dihydroxy-2-methyl-6-(1-methylethyl)-1H,4H-spiro{4,10a-methanopentaleno[1,6-cd]azonine-11,3-pyran}-9-carboxylate

C24H37NO5 (419.2672)


   

2-(indol-3-yl)ethyloctadeca-9Z,14Z-dien-12-ynoate

2-(indol-3-yl)ethyloctadeca-9Z,14Z-dien-12-ynoate

C28H37NO2 (419.2824)


   
   

Sinulamine III

Sinulamine III

C24H37NO5 (419.2672)


   

cespitulactam A

cespitulactam A

C28H37NO2 (419.2824)


   

10,23-dihydro-24,25-dehydro-21-oxo-aflavinine

10,23-dihydro-24,25-dehydro-21-oxo-aflavinine

C28H37NO2 (419.2824)


   

daphlongamine I

daphlongamine I

C24H37NO5 (419.2672)


   

daphmalenine A

daphmalenine A

C23H33NO6 (419.2308)


   

Isohericerin

Isohericerin

C27H33NO3 (419.246)


   
   

aspochalasin U

aspochalasin U

C24H37NO5 (419.2672)


   
   

Sinulamine II

Sinulamine II

C24H37NO5 (419.2672)


   
   
   
   

C24H37NO5_(7E)-11,12,13-Trihydroxy-3-isobutyl-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

NCGC00347828-02_C24H37NO5_(7E)-11,12,13-Trihydroxy-3-isobutyl-4,5,8-trimethyl-3,3a,4,6a,9,10,11,12,13,14-decahydro-1H-cycloundeca[d]isoindole-1,15(2H)-dione

C24H37NO5 (419.2672)


   

CP-728663

CP-728663

C26H33N3O2 (419.2573)


CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5898; ORIGINAL_PRECURSOR_SCAN_NO 5894 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5936; ORIGINAL_PRECURSOR_SCAN_NO 5934 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5937; ORIGINAL_PRECURSOR_SCAN_NO 5935 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5952; ORIGINAL_PRECURSOR_SCAN_NO 5951 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5960; ORIGINAL_PRECURSOR_SCAN_NO 5958 CONFIDENCE standard compound; INTERNAL_ID 506; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5960; ORIGINAL_PRECURSOR_SCAN_NO 5959

   

Ala Lys Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H33N5O7 (419.238)


   

Ala Thr Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]hexanamido]-3-hydroxybutanoic acid

C17H33N5O7 (419.238)


   

Ala Thr Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]hexanoic acid

C17H33N5O7 (419.238)


   

Lys Ala Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H33N5O7 (419.238)


   

Lys Ser Ser Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C17H33N5O7 (419.238)


   

Lys Ser Val Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C17H33N5O7 (419.238)


   

Lys Thr Ala Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]propanamido]-3-hydroxybutanoic acid

C17H33N5O7 (419.238)


   

Lys Thr Thr Ala

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]propanoic acid

C17H33N5O7 (419.238)


   

Lys Val Ser Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C17H33N5O7 (419.238)


   

Ser Lys Ser Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxypropanamido]-3-methylbutanoic acid

C17H33N5O7 (419.238)


   

Ser Lys Val Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-methylbutanamido]-3-hydroxypropanoic acid

C17H33N5O7 (419.238)


   

Ser Ser Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]hexanamido]-3-methylbutanoic acid

C17H33N5O7 (419.238)


   

Ser Ser Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-methylbutanamido]hexanoic acid

C17H33N5O7 (419.238)


   

Ser Val Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]hexanamido]-3-hydroxypropanoic acid

C17H33N5O7 (419.238)


   

Ser Val Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]-3-hydroxypropanamido]hexanoic acid

C17H33N5O7 (419.238)


   

Thr Ala Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]hexanamido]-3-hydroxybutanoic acid

C17H33N5O7 (419.238)


   

Thr Ala Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-hydroxybutanamido]hexanoic acid

C17H33N5O7 (419.238)


   

Thr Lys Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]propanamido]-3-hydroxybutanoic acid

C17H33N5O7 (419.238)


   

Thr Lys Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]-3-hydroxybutanamido]propanoic acid

C17H33N5O7 (419.238)


   

Thr Thr Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]propanamido]hexanoic acid

C17H33N5O7 (419.238)


   

Thr Thr Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]hexanamido]propanoic acid

C17H33N5O7 (419.238)


   

Val Lys Ser Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C17H33N5O7 (419.238)


   

Val Ser Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]hexanamido]-3-hydroxypropanoic acid

C17H33N5O7 (419.238)


   

Val Ser Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]hexanoic acid

C17H33N5O7 (419.238)


   

Stearidonyl carnitine

Stearidonyl carnitine

C25H41NO4 (419.3035)


   

N-palmitoyl tyrosine

N-hexadecanoyl-tyrosine

C25H41NO4 (419.3035)


   

N-oleoyl histidine

N-(9Z-octadecenoyl)-histidine

C24H41N3O3 (419.3148)


   

Hericerin

6-[(2Z)-3,7-dimethylocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-2,3-dihydro-1H-isoindol-1-one

C27H33NO3 (419.246)


   

ethyl amide-d4

17-phenyl trinor Prostaglandin F2&alpha

C25H33D4NO4 (419.2974)


   

CAR 18:4

3-[(4Z,8Z,12Z,15Z)-octadeca-4,8,12,15-tetraenoyloxy]-4-(trimethylazaniumyl)butanoate

C25H41NO4 (419.3035)


   

NA 25:5;O3

N-hexadecanoyl-tyrosine

C25H41NO4 (419.3035)


   

NAT 20:0

N-eicosanoyl taurine

C22H45NO4S (419.3069)


   

dicyclohexyl-[2-(2-methoxyphenyl)indol-1-yl]phosphane

dicyclohexyl-[2-(2-methoxyphenyl)indol-1-yl]phosphane

C27H34NOP (419.2378)


   

Cetilistat impurity 1

Cetilistat impurity 1

C25H41NO4 (419.3035)


   
   

2-Methyl-4-(N-ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone

2-Methyl-4-(N-ethyl-N-benzyl)aminobenzoaldehyde-1,1-diphenylhydrazone

C29H29N3 (419.2361)


   
   

Holmium nitrate pentahydrate

Holmium nitrate pentahydrate

Ho(NO3)3•5H2O (419.2956)


   

BUTYLACRYLATE-STYRENE-METHYLOLACRYLAMIDE-METHACRYLICACID

BUTYLACRYLATE-STYRENE-METHYLOLACRYLAMIDE-METHACRYLICACID

C23H33NO6 (419.2308)


   

SNC 162

4-[(S)-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]phenylmethyl]-N,N-diethylbenzamide

C27H37N3O (419.2936)


SNC162 is a delta-opioid receptor agonist with an IC50 of 0.94 nM. SNC162 has antidepressant-like effects and produces a selective enhancement of the antinociceptive effects of fentanyl in rhesus monkeys[1][2].

   

1-Ethoxycarbonyl-d-phe-pro-2(4-aminobutyl)hydrazine

1-Ethoxycarbonyl-d-phe-pro-2(4-aminobutyl)hydrazine

C21H33N5O4 (419.2532)


   

Prenylamine lactate

Prenylamine lactate

C27H33NO3 (419.246)


   
   
   

4,5,6-Trihydroxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

4,5,6-Trihydroxy-9,13,14-trimethyl-16-(2-methylpropyl)-17-azatricyclo[9.7.0.01,15]octadeca-9,12-diene-2,18-dione

C24H37NO5 (419.2672)


   

N-Palmitoyl-L-tyrosine

N-Palmitoyl-L-tyrosine

C25H41NO4 (419.3035)


   

N-icosanoyltaurine

N-icosanoyltaurine

C22H45NO4S (419.3069)


A fatty acid-taurine conjugate derived from icosanoic acid.

   

Prodigiosin R1

Prodigiosin R1

C27H37N3O (419.2936)


   

N-(2-Carboxyphenyl)retinamide

N-(2-Carboxyphenyl)retinamide

C27H33NO3 (419.246)


   

3-(1H-imidazol-5-yl)-2-[[(E)-octadec-9-enoyl]amino]propanoic acid

3-(1H-imidazol-5-yl)-2-[[(E)-octadec-9-enoyl]amino]propanoic acid

C24H41N3O3 (419.3148)


   

2-[(Z)-[17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]oxyacetic acid

2-[(Z)-[17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-ylidene]amino]oxyacetic acid

C23H33NO6 (419.2308)


   

N-Arachidonoyl Aspartic acid

N-Arachidonoyl Aspartic acid

C24H37NO5 (419.2672)


   

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoylcarnitine

(6Z,9Z,12Z,15Z)-Octadeca-6,9,12,15-tetraenoylcarnitine

C25H41NO4 (419.3035)


   

N-acetylsphingosine 1-phosphate(2-)

N-acetylsphingosine 1-phosphate(2-)

C20H38NO6P-2 (419.2437)


   

2-[2,5-Diethoxy-4-(4-morpholinyl)anilino]-1-(4-methyl-1-piperidinyl)-1-propanone

2-[2,5-Diethoxy-4-(4-morpholinyl)anilino]-1-(4-methyl-1-piperidinyl)-1-propanone

C23H37N3O4 (419.2784)


   

N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]cycloheptanecarboxamide

N-[2-[1-[2-(4-methylphenoxy)ethyl]-2-benzimidazolyl]ethyl]cycloheptanecarboxamide

C26H33N3O2 (419.2573)


   

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(5S,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(5S,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(5S,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7R,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(5R,6R,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(5R,6R,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(5R,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(5R,6S,9S)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(5R,6S,9R)-8-acetyl-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7R,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8S)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8R)-5-acetyl-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C22H33N3O5 (419.242)


   

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[2-(4-morpholinyl)-1-oxoethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C22H33N3O5 (419.242)


   
   

HexCer 8:1;2O/6:0

HexCer 8:1;2O/6:0

C20H37NO8 (419.2519)


   

HexCer 9:1;2O/5:0

HexCer 9:1;2O/5:0

C20H37NO8 (419.2519)


   

HexCer 12:1;2O/2:0

HexCer 12:1;2O/2:0

C20H37NO8 (419.2519)


   

HexCer 11:1;2O/3:0

HexCer 11:1;2O/3:0

C20H37NO8 (419.2519)


   

HexCer 10:1;2O/4:0

HexCer 10:1;2O/4:0

C20H37NO8 (419.2519)


   

(E)-3-hydroxy-2-(undecanoylamino)dec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(undecanoylamino)dec-4-ene-1-sulfonic acid

C21H41NO5S (419.2705)


   

(E)-2-(decanoylamino)-3-hydroxyundec-4-ene-1-sulfonic acid

(E)-2-(decanoylamino)-3-hydroxyundec-4-ene-1-sulfonic acid

C21H41NO5S (419.2705)


   

ETHAMOXYTRIPHETOL

4-Methoxy-alpha-[4-[2-(diethylamino)ethoxy]phenyl]-alpha-phenylbenzeneethanol

C27H33NO3 (419.246)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists

   

N-acetylsphingosine 1-phosphate(2-)

N-acetylsphingosine 1-phosphate(2-)

C20H38NO6P (419.2437)


A N-acylsphingosine 1-phosphate(2-) in which the N-acyl group is specified as acetyl; major species at pH 7.3.

   

SPHP(22:1)

SPHP(m22:1)

C22H46NO4P (419.3164)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

SPHP(21:2)

SPHP(d21:2)

C21H42NO5P (419.28)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-2AAA 18:4(6Z,9Z,12Z,15Z)

NA-2AAA 18:4(6Z,9Z,12Z,15Z)

C24H37NO5 (419.2672)


   

NA-Asp 20:4(5Z,8Z,11Z,14Z)

NA-Asp 20:4(5Z,8Z,11Z,14Z)

C24H37NO5 (419.2672)


   

NA-DOPA 15:1(9Z)

NA-DOPA 15:1(9Z)

C24H37NO5 (419.2672)


   

NA-His 18:1(9Z)

NA-His 18:1(9Z)

C24H41N3O3 (419.3148)


   

NA-Ser 22:4(7Z,10Z,13Z,16Z)

NA-Ser 22:4(7Z,10Z,13Z,16Z)

C25H41NO4 (419.3035)


   

NA-Taurine 20:0

NA-Taurine 20:0

C22H45NO4S (419.3069)


   
   
   

ST 21:3;O4;Gly

ST 21:3;O4;Gly

C23H33NO6 (419.2308)


   

ST 22:2;O3;Gly

ST 22:2;O3;Gly

C24H37NO5 (419.2672)


   

ST 23:1;O2;Gly

ST 23:1;O2;Gly

C25H41NO4 (419.3035)


   

GLX481304

GLX481304

C23H29N7O (419.2433)


GLX481304 is a specific inhibitor of Nox-2 and -4, with IC50s of 1.25 μM. GLX481304 suppresses ROS production in isolated mouse cardiomyocytes and improves cardiomyocyte contractility. GLX481304 can be used for research of ischemic injury to the heart[1].

   

(1r,3e,5s,10r)-5-hydroxy-3,17,17-trimethyl-7-methylidene-15-(2-phenylethyl)-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one

(1r,3e,5s,10r)-5-hydroxy-3,17,17-trimethyl-7-methylidene-15-(2-phenylethyl)-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one

C28H37NO2 (419.2824)


   

11-hydroxy-4-(1h-indol-3-yl)-5,7a,8-trimethyl-3-(prop-1-en-2-yl)-decahydro-2h-cyclohexa[e]naphthalen-1-one

11-hydroxy-4-(1h-indol-3-yl)-5,7a,8-trimethyl-3-(prop-1-en-2-yl)-decahydro-2h-cyclohexa[e]naphthalen-1-one

C28H37NO2 (419.2824)


   

6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

6-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.246)


   

14-debenzoylfranchetine

NA

C24H37NO5 (419.2672)


{"Ingredient_id": "HBIN001401","Ingredient_name": "14-debenzoylfranchetine","Alias": "NA","Ingredient_formula": "C24H37NO5","Ingredient_Smile": "CCN1CC2(CCC(C34C2CC(=C5CC(C6CC3C5C6O)OC)OC41)OC)COC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4805","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(4e,6z)-n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

(4e,6z)-n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C24H37NO5 (419.2672)


   

(1s,2r,5s,7r,8r,11s,14r)-1,2-dimethyl-7-(prop-1-en-2-yl)-6-oxa-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁶,²¹]tetracosa-9,15(23),16,18,20-pentaene-8,11-diol

(1s,2r,5s,7r,8r,11s,14r)-1,2-dimethyl-7-(prop-1-en-2-yl)-6-oxa-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁶,²¹]tetracosa-9,15(23),16,18,20-pentaene-8,11-diol

C27H33NO3 (419.246)


   

(3s,3ar,4s,6as,11s,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3s,3ar,4s,6as,11s,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C24H37NO5 (419.2672)


   

(2e,4e)-n-{5,6'-dihydroxy-3h-4',8'-dioxaspiro[furan-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

(2e,4e)-n-{5,6'-dihydroxy-3h-4',8'-dioxaspiro[furan-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

C23H33NO6 (419.2308)


   

(2e,4e,6r)-n-[(1's,3'r,4s,5r,5's,7'r)-5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

(2e,4e,6r)-n-[(1's,3'r,4s,5r,5's,7'r)-5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

C23H33NO6 (419.2308)


   

n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

n-(5,5-dimethyl-2-oxofuran-3-yl)-3-hydroxy-8-(3-octyloxiran-2-yl)octa-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

(4r,5r,10as,13s,13as,14s,16ar)-4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

(4r,5r,10as,13s,13as,14s,16ar)-4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

C24H37NO5 (419.2672)


   

(3r,4z,6e,9z)-n-[(3s,5s)-5-ethyl-5-methyl-2-oxooxolan-3-yl]-3-hydroxyoctadeca-4,6,9-trienimidic acid

(3r,4z,6e,9z)-n-[(3s,5s)-5-ethyl-5-methyl-2-oxooxolan-3-yl]-3-hydroxyoctadeca-4,6,9-trienimidic acid

C25H41NO4 (419.3035)


   

6-(3,7-dimethylocta-2,6-dien-1-yl)-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

6-(3,7-dimethylocta-2,6-dien-1-yl)-7-hydroxy-5-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.246)


   

2-(1h-indol-3-yl)ethyl (9z,14z)-octadeca-9,14-dien-12-ynoate

2-(1h-indol-3-yl)ethyl (9z,14z)-octadeca-9,14-dien-12-ynoate

C28H37NO2 (419.2824)


   

(1s,3e,5r,10s)-5-hydroxy-3,17,17-trimethyl-7-methylidene-15-(2-phenylethyl)-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one

(1s,3e,5r,10s)-5-hydroxy-3,17,17-trimethyl-7-methylidene-15-(2-phenylethyl)-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one

C28H37NO2 (419.2824)


   

(1s,2s,5s,7r,11r,14s)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one

(1s,2s,5s,7r,11r,14s)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one

C27H33NO3 (419.246)


   

9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

C24H37NO5 (419.2672)


   

1,2-dimethyl-7-(prop-1-en-2-yl)-6-oxa-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁶,²¹]tetracosa-9,15(23),16,18,20-pentaene-8,11-diol

1,2-dimethyl-7-(prop-1-en-2-yl)-6-oxa-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁶,²¹]tetracosa-9,15(23),16,18,20-pentaene-8,11-diol

C27H33NO3 (419.246)


   

13-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-2-(2-methylpropyl)-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

13-{[(z,5z)-4-methoxy-1h-[2,2'-bipyrrolyliden]-5-ylidene]methyl}-2-(2-methylpropyl)-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C27H37N3O (419.2936)


   

n-[2-(4-{[(2e)-3-methyl-4-(3-methylbut-2-en-1-yl)-5-oxohex-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[(2e)-3-methyl-4-(3-methylbut-2-en-1-yl)-5-oxohex-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C27H33NO3 (419.246)


   

(9z,13e)-18-[(dimethylamino)methyl]-4,9,13-trimethyl-17-oxo-5,16-dioxatricyclo[13.3.0.0⁴,⁶]octadeca-9,13-dien-3-yl acetate

(9z,13e)-18-[(dimethylamino)methyl]-4,9,13-trimethyl-17-oxo-5,16-dioxatricyclo[13.3.0.0⁴,⁶]octadeca-9,13-dien-3-yl acetate

C24H37NO5 (419.2672)


   

(3s,4r,4ar,5s,7ar,8s,11r,11as)-11-hydroxy-4-(1h-indol-3-yl)-5,7a,8-trimethyl-3-(prop-1-en-2-yl)-decahydro-2h-cyclohexa[e]naphthalen-1-one

(3s,4r,4ar,5s,7ar,8s,11r,11as)-11-hydroxy-4-(1h-indol-3-yl)-5,7a,8-trimethyl-3-(prop-1-en-2-yl)-decahydro-2h-cyclohexa[e]naphthalen-1-one

C28H37NO2 (419.2824)


   

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-8-ethoxy-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

(1s,2r,3r,4s,5s,6s,8s,9s,10r,13r,16s,17r)-8-ethoxy-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

C25H41NO4 (419.3035)


   

n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

methyl 7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

methyl 7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

(4e,6z)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

(4e,6z)-n-(5-ethyl-5-methyl-2-oxofuran-3-yl)-8-(3-heptyloxiran-2-yl)-3-hydroxyocta-4,6-dienimidic acid

C24H37NO5 (419.2672)


   

hexadecanoyl (2s)-2-amino-3-(4-hydroxyphenyl)propanoate

hexadecanoyl (2s)-2-amino-3-(4-hydroxyphenyl)propanoate

C25H41NO4 (419.3035)


   

(1r,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1r,2r,3r,4s,5r,6s,8s,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C24H37NO5 (419.2672)


   

(2e,4e)-n-{5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

(2e,4e)-n-{5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

C23H33NO6 (419.2308)


   

2-(1h-indol-3-yl)ethyl octadeca-9,14-dien-12-ynoate

2-(1h-indol-3-yl)ethyl octadeca-9,14-dien-12-ynoate

C28H37NO2 (419.2824)


   

methyl (1s,4as,4bs,7e,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4as,4bs,7e,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

n-[2-(4-{[3-methyl-4-(3-methylbut-2-en-1-yl)-5-oxohex-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

n-[2-(4-{[3-methyl-4-(3-methylbut-2-en-1-yl)-5-oxohex-2-en-1-yl]oxy}phenyl)ethyl]benzenecarboximidic acid

C27H33NO3 (419.246)


   

(1s,2r,3r,4s,5s,6s,8r,9s,10r,13r,16s,17r)-11-ethyl-4-hydroxy-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-one

(1s,2r,3r,4s,5s,6s,8r,9s,10r,13r,16s,17r)-11-ethyl-4-hydroxy-6,8,16-trimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-18-one

C24H37NO5 (419.2672)


   

5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-6-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

5-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-4-hydroxy-6-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.246)


   

13-({4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)-2-(2-methylpropyl)-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

13-({4-methoxy-1'h-[2,2'-bipyrrol]-5-ylidene}methyl)-2-(2-methylpropyl)-12-azabicyclo[9.2.1]tetradeca-1(13),11(14)-diene

C27H37N3O (419.2936)


   

n-{5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

n-{5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl}-4,6-dimethyldodeca-2,4-dienimidic acid

C23H33NO6 (419.2308)


   

1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C24H37NO5 (419.2672)


   

(1r,5r,6s,7r,10s,11r,12s,15r,16s)-9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

(1r,5r,6s,7r,10s,11r,12s,15r,16s)-9-(hydroxymethyl)-5,10-dimethyl-12-(2-methylpropyl)-19-oxa-13-azapentacyclo[14.2.1.0¹,⁶.0⁷,¹⁵.0¹¹,¹⁵]nonadeca-8,13-diene-5,14,16-triol

C24H37NO5 (419.2672)


   

(3z,5e,12r,15e,17z,19z,21e,23z,25r)-2,12-dihydroxy-9,25-dimethyl-1-azacyclohexacosa-1,3,5,7,9,15,17,19,21,23-decaen-14-one

(3z,5e,12r,15e,17z,19z,21e,23z,25r)-2,12-dihydroxy-9,25-dimethyl-1-azacyclohexacosa-1,3,5,7,9,15,17,19,21,23-decaen-14-one

C27H33NO3 (419.246)


   

n-(5-ethyl-5-methyl-2-oxooxolan-3-yl)-3-hydroxyoctadeca-4,6,9-trienimidic acid

n-(5-ethyl-5-methyl-2-oxooxolan-3-yl)-3-hydroxyoctadeca-4,6,9-trienimidic acid

C25H41NO4 (419.3035)


   

6-acetyl-3-[(dimethylamino)methyl]-9,13-dimethyl-2-oxo-3h,3ah,4h,5h,6h,7h,8h,11h,12h,14ah-cyclotrideca[b]furan-5-yl acetate

6-acetyl-3-[(dimethylamino)methyl]-9,13-dimethyl-2-oxo-3h,3ah,4h,5h,6h,7h,8h,11h,12h,14ah-cyclotrideca[b]furan-5-yl acetate

C24H37NO5 (419.2672)


   

8-ethoxy-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

8-ethoxy-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

C25H41NO4 (419.3035)


   

methyl (1r,5s,8s,11s,12r,15r,17r)-8-hydroxy-3-methyl-9-oxo-15-(3-oxopentyl)-13-oxa-3-azapentacyclo[9.4.2.0¹,¹².0⁵,¹⁵.0⁸,¹²]heptadecane-17-carboxylate

methyl (1r,5s,8s,11s,12r,15r,17r)-8-hydroxy-3-methyl-9-oxo-15-(3-oxopentyl)-13-oxa-3-azapentacyclo[9.4.2.0¹,¹².0⁵,¹⁵.0⁸,¹²]heptadecane-17-carboxylate

C23H33NO6 (419.2308)


   

methyl (1s,4as,4bs,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4as,4bs,8r,8ar,10ar)-1,4a,8-trimethyl-7-{2-[2-(methylamino)ethoxy]-2-oxoethylidene}-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

5-(2-hydroxy-4-{[(2e)-1-hydroxy-4,6,8-trimethylnona-2,7-dien-1-ylidene]amino}-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl)pentanoic acid

5-(2-hydroxy-4-{[(2e)-1-hydroxy-4,6,8-trimethylnona-2,7-dien-1-ylidene]amino}-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-2-yl)pentanoic acid

C23H33NO6 (419.2308)


   

(1s,2s,3s,4s,5r,6r,8r,9s,10r,13r,16r,17r)-8-ethoxy-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

(1s,2s,3s,4s,5r,6r,8r,9s,10r,13r,16r,17r)-8-ethoxy-11-ethyl-6,16-dimethoxy-13-methyl-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-ol

C25H41NO4 (419.3035)


   

7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one

7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one

C27H33NO3 (419.246)


   

(2e,4e,6r)-n-[(1's,3'r,5's,7'r)-5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

(2e,4e,6r)-n-[(1's,3'r,5's,7'r)-5-hydroxy-6'-oxo-4',8'-dioxaspiro[oxolane-2,2'-tricyclo[5.1.0.0³,⁵]octan]-4-yl]-4,6-dimethyldodeca-2,4-dienimidic acid

C23H33NO6 (419.2308)


   

methyl (1s,4ar,4bs,7e,8r,8as,10ar)-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

methyl (1s,4ar,4bs,7e,8r,8as,10ar)-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-9-oxo-decahydrophenanthrene-1-carboxylate

C24H37NO5 (419.2672)


   

5-hydroxy-3,17,17-trimethyl-7-methylidene-15-(2-phenylethyl)-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one

5-hydroxy-3,17,17-trimethyl-7-methylidene-15-(2-phenylethyl)-15-azatricyclo[8.5.2.0¹³,¹⁶]heptadeca-3,13(16)-dien-14-one

C28H37NO2 (419.2824)


   

(1r,2s,3s,4s,5s,6r,8r,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

(1r,2s,3s,4s,5s,6r,8r,9s,10r,13r,16s,17r)-11-ethyl-8-hydroxy-6,16-dimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl acetate

C24H37NO5 (419.2672)


   

(3s,3ar,4s,6as,11r,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

(3s,3ar,4s,6as,11r,12s,13s,15ar)-1,11,12,13-tetrahydroxy-4,5,8-trimethyl-3-(2-methylpropyl)-3h,3ah,4h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one

C24H37NO5 (419.2672)


   

5-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-6-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

5-(3,7-dimethylocta-2,6-dien-1-yl)-4-hydroxy-6-methoxy-2-(2-phenylethyl)-3h-isoindol-1-one

C27H33NO3 (419.246)


   

4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

4,5,16-trihydroxy-9,12,13-trimethyl-14-(2-methylpropyl)-3h,4h,5h,6h,7h,8h,10ah,13h,13ah,14h-oxacyclododeca[2,3-d]isoindol-2-one

C24H37NO5 (419.2672)